Striking a Balance in Cardiovascular Device Manufacturing

Table of Contents

1. Quality and Standards
2. Cost and Affordability
3. Supply Chain Efficiency
4. Research and Development (R&D)
5. Regulatory Challenges
6. Employment and Economic Impact
7. Conclusion

The demand for cardiovascular devices such as stents and catheters is growing rapidly in India due to the increasing prevalence of heart diseases. With over 32 lakh angioplasty procedures conducted annually, ensuring a consistent supply of quality devices is critical. This raises an important question: should India focus on local manufacturing or rely on imports? Let’s explore the challenges and opportunities in both approaches.

1. Quality and Standards

• Local Manufacturing:
  Indian manufacturers face stringent quality benchmarks set by the Central Drugs Standard Control Organization (CDSCO). While Indian companies have made strides in maintaining global standards, establishing credibility in international markets remains a challenge.
  
• Importing:
  Imported devices, primarily from the US and Europe, are often seen as superior due to advanced technologies and established regulatory compliance. However, they may not always be optimized for local patient demographics or conditions.

2. Cost and Affordability

• Local Manufacturing:
  Domestic production can reduce costs significantly, as evidenced by the price caps on coronary stents introduced by India’s National Pharmaceutical Pricing Authority (NPPA). Locally manufactured stents are often 30-40% cheaper than imported ones, making them more accessible.
  
• Importing:
  Imported devices carry higher costs due to tariffs, shipping, and currency fluctuations. Despite this, they dominate certain market segments, particularly in high-end, technologically advanced devices.

3. Supply Chain Efficiency

• Local Manufacturing:
  Domestic production reduces dependency on complex international supply chains. However, challenges like sourcing high-quality raw materials and ensuring manufacturing precision persist. Local suppliers often face delays due to inadequate infrastructure and inconsistent raw material quality.
  
• Importing:
  Imports can provide a steady supply of high-quality devices, but global disruptions, such as the COVID-19 pandemic, have highlighted vulnerabilities in over-reliance on international logistics.

4. Research and Development (R&D)

• Local Manufacturing:
  India’s medical device industry invests significantly less in R&D compared to global players. However, initiatives like the Production Linked Incentive (PLI) Scheme aim to bolster local innovation. Emerging startups are also contributing to R&D for customized stents and biodegradable technologies.
  
• Importing:
  Imported devices benefit from cutting-edge R&D investments made in developed countries. However, these innovations may not always align with the specific needs of Indian patients or healthcare providers.

5. Regulatory Challenges

• Local Manufacturing:
  Indian manufacturers must navigate both domestic and international regulatory landscapes. Adhering to standards like ISO 13485 and obtaining certifications for exports require significant investments in time and resources.
  
• Importing:
  Imported devices undergo rigorous approval processes under CDSCO. However, delays in approval and additional compliance costs can impact their timely availability in the Indian market.

---

6. Employment and Economic Impact

• Local Manufacturing:
  Expanding domestic production creates job opportunities across manufacturing, R&D, and distribution. According to a CII report, India’s medical device sector has the potential to generate 4-5 lakh jobs in the next decade.
  
• Importing:
  While imports support high-quality healthcare delivery, they contribute less to the local economy and do not address the employment gap in the medical device manufacturing sector.

Conclusion

The choice between local manufacturing and importing cardiovascular devices involves balancing cost, quality, and accessibility. While local production is key to affordability and economic growth, investments in R&D, infrastructure, and quality assurance are essential to compete globally. On the other hand, imports provide immediate access to advanced technologies but come at a higher cost and dependency on foreign markets.

India’s long-term strategy should focus on building a robust domestic ecosystem, leveraging government initiatives like the PLI Scheme and promoting collaborations between academia, startups, and established manufacturers to create a self-reliant and innovative cardiovascular device industry.